Ofir Wolach
Petah Tiqwa, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.
Journal: Haematologica
Published: August 08, 2026
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.
Journal: Leukemia & lymphoma
Published: July 29, 2026
Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.
Journal: Leukemia research
Published: June 07, 2026
MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML.
Journal: Annals of hematology
Published: January 29, 2026
MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML.
Journal: Annals of hematology
Published: January 29, 2026
Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study.
Journal: Frontiers in immunology
Published: December 21, 2025
Silver bullets for the golden age: treating IDH-mutated acute myeloid leukemia in older patients.
Journal: Haematologica
Published: November 24, 2025
Glucose-6-phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine.
Journal: Cancer
Published: October 03, 2025
Germline POT1 variants are associated with long telomeres and an unexpected broad spectrum of malignancies.
Journal: Genetics in medicine open
Published: August 18, 2025
Beating the STATs: targeting the metabolome in acute myeloid leukemia.
Journal: Haematologica
Published: August 11, 2025
Last Updated: 09/26/2026